以上内容来自Benzinga Earnings专栏,原文如下:
Exact Sciences (NASDAQ:EXAS) reported quarterly sales of $713.00 million which beat the analyst consensus estimate of $701.30 million by 1.67 percent. This is a 10.22 percent increase over sales of $646.88 million the same period last year.